Ruxolitinib rechallenge in combination with hydroxyurea is effective in reverting cachexia and reducing blood transfusion demand and splenomegaly symptoms in a patient with primary myelofibrosis
Crossref DOI link: https://doi.org/10.1007/s00277-017-2938-5
Published Online: 2017-02-14
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cerchione, Claudio
Peluso, Ilaria
Nappi, Davide
Pareto, Anna Emanuele
Picardi, Marco
Martinelli, Vincenzo
Pane, Fabrizio
License valid from 2017-02-14